Mark Hedelius in Lehi, Utah

Home Utah Lehi

Mark Hedelius has Certified Registered Nurse Anesthetist (crna) as his primary medical specialty. Their primary office is: 3000 N Triumph Blvd in Lehi, Utah. There is an additional office location, for a total of two, for Mark Hedelius that can be viewed further down.

They're a part of the: Alpine Anesthesia Llc medical group which has around 15 members. You can call their office at 801-636-6597 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2018 (around 6 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Mark W Hedelius Office Phone and Directions

Mark Hedelius
Alpine Anesthesia Llc
3000 N Triumph Blvd
Lehi, Utah 84043
801-636-6597

Patient Ratings
Please rate your experience with Mark Hedelius below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 801-636-6597

Enter a starting address:

Healthcare Info for Mark Hedelius

Medical School: Sorry, his university is not listed
Graduation Year: 2018
The Primary Medical Specialty for Mark Hedelius is listed as: Certified Registered Nurse Anesthetist (crna)
Approximate Years of Experience: 6
PAC (PECOS ID)#: 3870831621
NPI #: 1417428194
NPI Created On: 12/06/2018
NPI Last Updated Listed as: 11/02/2023
Primary Taxonomy Code: 163W00000X
License Number:
8006124-3102
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848500759

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: NEUROSCIENCE

Name of Drug #1: BRIDION

Open Associated Drug #1: 0006-5423-15